Stock MAXHEALTH MAX HEALTHCARE INSTITUTE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Max Healthcare Institute Limited NSE India S.E.

Equities

MAXHEALTH

INE027H01010

Healthcare Facilities & Services

End-of-day quote NSE India S.E.
Other stock markets
 06:00:00 2024-06-03 pm EDT 		5-day change 1st Jan Change
780.8 INR +2.03% Intraday chart for Max Healthcare Institute Limited -1.41% +13.77%
May. 30 India's Apollo Hospitals misses Q4 profit estimates on higher expenses RE
May. 24 Jefferies Adjusts Max Healthcare’s Price Target to INR940 From INR915, Keeps at Buy MT

Valuation

Fiscal Period: Marzo 2021 2022 2023 2024 2025 2026
Capitalization 1 199,033 336,359 428,177 761,396 - -
Enterprise Value (EV) 1 203,285 340,500 420,386 797,357 753,578 740,115
P/E ratio -130 x 55.6 x 38.8 x 75.7 x 49.2 x 38.4 x
Yield - - 0.23% 0.17% 0.21% 0.26%
Capitalization / Revenue 7.95 x 8.56 x 9.38 x 14.7 x 9.38 x 7.43 x
EV / Revenue 8.12 x 8.66 x 9.21 x 14.7 x 9.28 x 7.22 x
EV / EBITDA 50.3 x 36.1 x 33.9 x 53.4 x 33.3 x 25.8 x
EV / FCF - 182 x 48.1 x 306 x 111 x 60.4 x
FCF Yield - 0.55% 2.08% 0.33% 0.9% 1.65%
Price to Book 3.53 x 5.35 x 5.78 x 8.32 x 7.22 x 6.15 x
Nbr of stocks (in thousands) 965,945 969,613 970,923 971,912 - -
Reference price 2 206.0 346.9 441.0 783.4 783.4 783.4
Announcement Date 5/28/21 5/25/22 5/16/23 5/22/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2021 2022 2023 2024 2025 2026
Net sales 1 25,047 39,315 45,626 54,060 81,215 102,493
EBITDA 1 4,039 9,426 12,405 14,921 22,640 28,733
EBIT 1 2,298 7,214 10,083 12,471 19,102 24,543
Operating Margin 9.17% 18.35% 22.1% 23.07% 23.52% 23.95%
Earnings before Tax (EBT) 1 -686.5 7,389 10,637 13,653 18,934 24,221
Net income 1 -1,145 6,050 11,035 10,576 15,748 20,463
Net margin -4.57% 15.39% 24.19% 19.56% 19.39% 19.97%
EPS 2 -1.590 6.240 11.36 10.84 15.93 20.42
Free Cash Flow 1 - 1,872 8,736 2,442 6,779 12,247
FCF margin - 4.76% 19.15% 3.56% 8.35% 11.95%
FCF Conversion (EBITDA) - 19.86% 70.42% 13.03% 29.94% 42.62%
FCF Conversion (Net income) - 30.94% 79.16% 18.47% 43.05% 59.85%
Dividend per Share 2 - - 1.000 1.312 1.656 2.033
Announcement Date 5/28/21 5/25/22 5/16/23 5/22/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 7,956 8,019 10,002 10,183 9,742 9,388 10,003 11,371 11,412 12,145 12,850 16,799 16,892 17,895
EBITDA 1 1,601 1,681 3,600 3,620 2,458 2,103 2,644 3,188 3,134 3,403 3,374 4,581 4,673 4,990
EBIT 1 1,117 1,205 - - - - 2,072 2,612 2,564 2,800 2,816 3,775 3,792 4,132
Operating Margin 14.04% 15.03% - - - - 20.72% 22.97% 22.47% 23.05% 21.91% 22.47% 22.45% 23.09%
Earnings before Tax (EBT) 1 - - - - - - 2,164 2,652 2,814 3,007 3,035 3,849 4,164 4,314
Net income 1 - - - - - - 1,728 4,574 2,224 2,509 2,401 3,160 3,456 3,520
Net margin - - - - - - 17.28% 40.22% 19.49% 20.66% 18.68% 18.81% 20.46% 19.67%
EPS 2 1.000 0.7500 - 1.490 1.960 1.270 1.780 4.710 2.290 2.580 2.460 3.240 3.397 3.525
Dividend per Share 2 - - - - - - - - - 1.000 - - - -
Announcement Date 2/6/21 5/28/21 8/10/21 11/12/21 2/12/22 5/25/22 8/10/22 11/1/22 2/2/23 5/16/23 8/7/23 - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Net Debt 1 4,252 4,141 - - - -
Net Cash position 1 - - 7,791 13,603 7,819 21,281
Leverage (Debt/EBITDA) 1.053 x 0.4393 x - - - -
Free Cash Flow 1 - 1,872 8,736 2,443 6,779 12,247
ROE (net income / shareholders' equity) -3.36% 10.3% 16.1% 15.1% 15.6% 16.8%
ROA (Net income/ Total Assets) -2.2% 6.91% 11.4% 11.7% 12.1% 13.2%
Assets 1 52,102 87,600 96,455 113,463 130,053 155,063
Book Value Per Share 2 58.40 64.80 76.30 94.10 109.0 127.0
Cash Flow per Share 2 - 7.720 12.50 12.60 14.50 19.90
Capex 1 1,184 5,613 3,356 11,083 13,678 13,663
Capex / Sales 4.73% 14.28% 7.36% 16.17% 16.84% 13.33%
Announcement Date 5/28/21 5/25/22 5/16/23 5/22/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Max Healthcare Institute Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
783.4 INR
Average target price
855.1 INR
Spread / Average Target
+9.15%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+22.65% 86.96B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-23.68% 75.65B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
0.00% 26.97B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+4.74% 17.89B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-13.47% 16.58B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.68% 15.73B
NATERA, INC. Stock Natera, Inc.
+69.13% 13.01B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+74.99% 12.92B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+3.82% 12.5B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. MAXHEALTH Stock
  4. MAXHEALTH Stock
  5. Financials Max Healthcare Institute Limited